Kayne Anderson Rudnick Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.98K | Sell |
|
|||||
|
2025
Q2 | $6.71K | Buy |
|
|||||
|
2025
Q1 | $4.03K | Sell |
|
|||||
|
2024
Q4 | $1.49M | Sell |
|
|||||
|
2024
Q3 | $1.44M | Sell |
|
|||||
|
2024
Q2 | $1.19M | Sell |
|
|||||
|
2024
Q1 | $3.4M | Sell |
|
|||||
|
2023
Q4 | $3.34M | Sell |
|
|||||
|
2023
Q3 | $3.94M | Sell |
|
|||||
|
2023
Q2 | $4.38M | Sell |
|
|||||
|
2023
Q1 | $6.53M | Hold |
|
|||||
|
2022
Q4 | $6.78M | Sell |
|
|||||
|
2022
Q3 | $6.98M | Buy |
|
|||||
|
2022
Q2 | $33K | Sell |
|
|||||
|
2022
Q1 | $39K | Buy |
|
|||||
|
2021
Q4 | $27K | Hold |
|
|||||
|
2021
Q3 | $25K | Hold |
|
|||||
|
2021
Q2 | $29K | Hold |
|
|||||
|
2021
Q1 | $27K | Hold |
|
|||||
|
2020
Q4 | $26K | Hold |
|
|||||
|
2020
Q3 | $26K | Buy |
|
|||||
|
2020
Q2 | $7K | Hold |
|
|||||
|
2020
Q1 | $7K | Hold |
|
|||||
|
2019
Q4 | $8K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $11.2M | Sell |
|
|||||
|
2016
Q4 | $25.3M | Sell |
|
|||||
|
2016
Q3 | $25.6M | Buy |
|
|||||
|
2016
Q2 | $24.8M | Sell |
|
|||||
|
2016
Q1 | $21.8M | Buy |
|
|||||
|
2015
Q4 | $15.9M | Sell |
|
|||||
|
2015
Q3 | $13.9M | Sell |
|
|||||
|
2015
Q2 | $15.9M | Sell |
|
|||||
|
2015
Q1 | $15.6M | Buy |
|
|||||
|
2014
Q4 | $7.42M | Buy |
|